Skip to main content

Table 3 Random sample; number of prescriptions, therapy groups and clinical evaluation

From: Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care

Treatment Total Recorded asthma diagnosis Recorded COPD diagnosis Provisional diagnoses Trial by medication Off-label prescribing
  n n (%) n (%) n (%) n (%) n (%)
All patients 670 320 (48) 71 (11) 44 (7) 85 (13) 150 (22)
Number of prescriptions 1       
 1 prescription 332 135 (42) 22 (31) 25 (57) 34 (40) 116 (77)
 2 prescriptions 196 117 (37) 16 (23) 15 (34) 26 (31) 22 (15)
  ≥ 3 prescriptions 142 68 (21) 33 (46) 4 (9) 25 (29) 12 (8)
Therapy groups 2       
 SABA only 207 54 (17) 15 (21) 14 (32) 29 (34) 95 (63)
 ICS and SABA 141 83 (26) 7 (10) 13 (30) 24 (28) 14 (9)
 ICS and LABA 91 55 (17) 12 (17) 7 (16) 6 (7) 11 (7)
 Fixed combination of ICS/LABA 175 102 (32) 34 (48) 8 (18) 17 (20) 14 (9)
 ICS only3 56 26 (8) 3 (4) 2 (5) 9 (11) 16 (11)
Clinical evaluation       
 PEF4 only 36 25 (8) 1 (1) 1 (2) 2 (2) 7 (5)
 Spirometry 207 110 (34) 37 (52) 16 (36) 24 (28) 20 (13)
  1. 1Number of prescriptions = number of occasions where the patient had one or more medications prescribed.
  2. 2Therapy groups according to the treatment steps in the therapy recommendations, SABA = Short acting β2-agonists; LABA = Long-acting β2- agonists; ICS = Inhaled Corticosteroids.
  3. 3ICS is not recommended as monotherapy.
  4. 4PEF = Peak Expiratory Flow.